Looking back at my 2024 predictions in the healthcare industry, it’s clear that some of my forecasts were on point while others missed the mark. As I reflect on the state of the industry and the changing landscape, it’s time to revisit my initial projections and see how they have played out over the past year.
First and foremost, I predicted that presidential candidates would largely remain silent on healthcare issues in 2024. Unfortunately, this turned out to be true as the subject was not a focal point of the campaign. Moving forward, I anticipate that discussions around healthcare will shift towards mainstream acceptance of science-based healers, especially when individuals are in need of medical care.
In terms of mergers and acquisitions, while I predicted a rise in mega-mergers, the actual trend in 2024 saw a steady number of mergers with a slight decrease in deal volume compared to the previous year. Hospital mergers were on the rise, indicating a continued trend towards consolidation in the healthcare industry.
The growth of Medicare Advantage enrollment in 2024 remained steady, debunking my prediction that criticism of the program would lead to a slowdown. With the Biden administration proposing increased payments to MA plans and support from the likely new CMS administrator, Dr. Mehmet Oz, Medicare Advantage is expected to continue its growth trajectory in the coming years.
Venture funding for digital health saw a decline in 2024, but I anticipate new startups with realistic valuations and innovative solutions to emerge, especially as artificial intelligence becomes more prevalent in healthcare. Additionally, the popularity of GLP-1 medications like Ozempic and Mounjaro is on the rise, changing the landscape of obesity treatment and expanding their use for various conditions.
Unfortunately, my prediction about backlash against DEI initiatives came true in 2024, with a decrease in demand for chief diversity officers attributed to conservative opposition. Despite these challenges, many healthcare organizations remain committed to promoting health equity, and efforts in this area are expected to continue despite government headwinds.
In terms of clinician morale, the number of physicians reporting burnout decreased in 2024, but the issue remains prevalent. To address this problem, a revolution in healthcare leadership and management is crucial to support frontline staff and improve overall well-being.
Looking ahead, turnover at the top of healthcare organizations is expected in 2024, with many long-tenured leaders stepping down amid industry challenges. This turnover will create opportunities for new leadership to guide organizations through a changing environment.
Lastly, I predicted that at least one big tech company would fold or reboot its healthcare efforts in 2024. While Amazon made significant moves in the healthcare space, other tech giants are also shaping their healthcare strategies. I anticipate that select big tech players will continue to advance solutions to improve the accuracy of health information.
Overall, my predictions for 2024 were a mix of hits and misses, showcasing the dynamic nature of the healthcare industry. As I look towards 2025, I am excited to see how these trends continue to evolve and shape the future of healthcare.
